Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Total Non-Current Liabilities (2020 - 2025)

PROCEPT BioRobotics has reported Total Non-Current Liabilities over the past 6 years, most recently at $142.1 million for Q4 2025.

  • Quarterly results put Total Non-Current Liabilities at $142.1 million for Q4 2025, up 8.06% from a year ago — trailing twelve months through Dec 2025 was $142.1 million (up 8.06% YoY), and the annual figure for FY2025 was $142.1 million, up 8.06%.
  • Total Non-Current Liabilities for Q4 2025 was $142.1 million at PROCEPT BioRobotics, up from $130.7 million in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for PRCT hit a ceiling of $142.1 million in Q4 2025 and a floor of $66.6 million in Q1 2022.
  • Median Total Non-Current Liabilities over the past 5 years was $119.1 million (2023), compared with a mean of $110.6 million.
  • Biggest five-year swings in Total Non-Current Liabilities: skyrocketed 64.38% in 2023 and later fell 1.33% in 2025.
  • PROCEPT BioRobotics' Total Non-Current Liabilities stood at $68.4 million in 2021, then skyrocketed by 64.03% to $112.3 million in 2022, then increased by 9.97% to $123.4 million in 2023, then grew by 6.5% to $131.5 million in 2024, then grew by 8.06% to $142.1 million in 2025.
  • The last three reported values for Total Non-Current Liabilities were $142.1 million (Q4 2025), $130.7 million (Q3 2025), and $127.0 million (Q2 2025) per Business Quant data.